FrancophonIA/ELRC3.0 huggingface dataset:
English: Hypoglycaemia Repaglinide, like other insulin secretagogues, is capable of producing hypoglycaemia.
Slovenian: Tako kot drugi sekretagogi insulina lahko tudi repaglinid povzroči hipoglikemijo.
English: Repaglinide is given preprandially and is titrated individually to optimise glycaemic control.
Slovenian: Odmerjanje Repaglinid se uporablja predprandialno in ga je treba za optimiranje urejenosti glukoze v krvi individualno prilagoditi.
English: The following substances may enhance and/or prolong the hypoglycaemic effect of repaglinide: Gemfibrozil, clarithromycin, itraconazole, ketokonazole, trimethoprim, ciclosporin, deferasirox, clopidogrel, other antidiabetic substances, monoamine oxidase inhibitors (MAOI), non selective beta blocking substances, angiotensin converting enzyme (ACE)-inhibitors, salicylates, NSAIDs, octreotide, alcohol, and anabolic steroids.
Slovenian: klaritromicin, itrakonazol, ketokonazol, trimetoprim, ciklosporin, deferasiroks, klopidogrel, drugi antidiabetiki, zaviralci monoaminooksidaze (MAOI), neselektivni zaviralci beta, zaviralci angiotenzinske konvertaze (ACE), salicilati, NSAID, oktreotid, alkohol in anabolni steroidi.
English: • Thyroid products (used to treat low levels of thyroid hormones).
Slovenian: • zdravila za ščitnico (uporabljajo se za zdravljenje nizke ravni ščitničnih hormonov),
English: Should these symptoms occur, adequate action should be taken to correct the low blood glucose (oral carbohydrates).
Slovenian: je treba ustrezno ukrepati, da bi odpravili nizko glukozo v krvi (zaužitje ogljikovih hidratov).
English: Repaglinide should be used with caution or be avoided in patients receiving medicinal products which influence repaglinide metabolism (see section 4.5).
Slovenian: Pri bolnikih, ki dobivajo zdravila z vplivom na presnovo repaglinida, morate repaglinid uporabiti previdno ali se mu izogniti (glejte poglavje 4.5).
English: • Monoamine oxidase inhibitors (MAOI) (used to treat depression).
Slovenian: • zaviralce monoaminooksidaze (zaviralce MAO) (za zdravljenje depresij),
English: Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG, United Kingdom
Slovenian: TEVA UK Ltd Brampton Road Hampden Park Eastbourne, East Sussex BN22 9AG
English: Co-administration of 100 mg itraconazole, an inhibitor of CYP3A4, has also been studied in healthy volunteers, and increased the AUC by 1.4-fold.
Slovenian: Pri zdravih prostovoljcih so raziskali tudi sočasno uporabo 100 mg itrakonazola, inhibitorja CYP3A4, pri čemer se je AUC zvečal za 1,4-krat.
English: Repaglinide Teva is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).
Slovenian: Kaj je zdravilo Repaglinid Teva in za kaj ga uporabljamo Zdravilo Repaglinid Teva je peroralni antidiabetik z repaglinidom, ki trebušni slinavki pomaga, da tvori več insulina, in tako znižuje sladkor v krvi (glukozo).
English: How to take Repaglinide Teva
Slovenian: Kako jemati zdravilo Repaglinid Teva
English: • If you exercise more than usual.
Slovenian: • jeste več kot ponavadi,
English: In debilitated or malnourished patients the initial and maintenance dosage should be conservative and careful dose titration is required to avoid hypoglycaemic reactions.
Slovenian: Pri oslabelih in podhranjenih bolnikih mora biti začetno in vzdrževalno odmerjanje konzervativno;
English: In vitro data indicate that repaglinide is metabolised predominantly by CYP2C8, but also by CYP3A4.
Slovenian: Podatki in vitro raziskav nakazujejo, da se repaglinid presnavlja pretežno z CYP2C8, vendar tudi z
English: • Gemfibrozil (used to treat high blood fats).
Slovenian: • gemfibrozil (zdravilo za zdravljenje povišanih maščob v krvi),
English: • If you take too much Repaglinide Teva.
Slovenian: • ste vzeli preveč zdravila Repaglinid Teva,
English: Co-administration of cimetidine, nifedipine, oestrogen, or simvastatin with repaglinide, all CYP3A4 substrates, did not significantly alter the pharmacokinetic parameters of repaglinide.
Slovenian: Sočasna uporaba drugih snovi, ki se presnavljajo s CYP3A4, npr. cimetidina, nifedipina, estrogena ali simvastatina z repaglinidom, ni pomembno spremenila farmakokinetičnih lastnosti repaglinida.
English: A dose-dependent decrease in blood glucose was demonstrated in type 2 diabetic patients when administered in doses from 0.5 to 4 mg repaglinide.
Slovenian: Pri bolnikih s sladkorno boleznijo tipa 2 so med uporabo odmerkov od 0,5 do 4 mg repaglinida dokazali od odmerka odvisno znižanje glukoze v krvi.
English: - The other ingredients are: microcrystalline cellulose (E460), meglumine, poloxamer 188, povidone K-30, calcium hydrogen phosphate anhydrous, colloidal silicon dioxide anhydrous, polacrilin potassium, maize starch, magnesium stearate, indigo carmine aluminium (E132) (0.5 mg tablet only), iron oxide yellow (E172) (1 mg tablet only), iron oxide red (E172) (2 mg tablet only)
Slovenian: - Pomožne snovi so: mikrokristalna celuloza (E460), meglumin, poloksamer 188, povidon K-30, brezvodni kalcijev hidrogenfosfat, brezvodni koloidni silicijev dioksid, polakrilin kalij, koruzni škrob, magnezijev stearat, indigotin (E132)(samo v 0,5 mg tabletah), rumeni železov oksid (E172) (samo v 1 mg tabletah), rdeči železov oksid (samo v 2 mg tabletah)
English: After a 5 day treatment of repaglinide (2 mg x 3/day) in patients with a severe impaired renal function (creatinine clearance: 20-39 ml/min.
Slovenian: Pri bolnikih s hudo okvaro delovanja ledvic (očistek kreatinina: 20-39 ml/min) so rezultati po 5-dnevnem zdravljenju z repaglinidom
English: Repaglinide Teva 2 mg tablets EU/1/09/530/011-015
Slovenian: Repaglinid Teva 2 mg tablete EU/1/09/530/011-015
English: Repaglinide Teva 1 mg tablets EU/1/09/530/006-010
Slovenian: Repaglinid Teva 1 mg tablete EU/1/09/530/006-010
English: What you need to know before you take Repaglinide Teva
Slovenian: Kaj morate vedeti, preden boste vzeli zdravilo Repaglinid Teva Ne jemljite zdravila Repaglinid Teva
English: Combination with Neutral Protamine Hagedorn (NPH) insulin or thiazolidinediones Trials of combination therapy with NPH insulin or thiazolidinediones have been performed.
Slovenian: Kombinacija z insulinom NPH (Neutral Protamine Hagedorn) ali s tiazolidindioni Preskušanja s kombiniranim zdravljenjem z NPH insulinom ali s tiazolidindioni so bila izvedena, vendar je treba profil koristi in tveganja še ugotoviti v primerjavi z drugimi kombiniranimi zdravljenji.
English: The resulting increased calcium influx induces insulin secretion from the β-cell.
Slovenian: Vdor kalcija v celico se zato zveča in to sproži izločanje insulina iz celice β.
English: The safety and efficacy of repaglinide in children below 18 years have not been established.
Slovenian: Uporaba repaglinida ni priporočljiva pri otrocih in mladostnikih, mlajših od 18 let, zaradi pomanjkanja podatkov o varnosti in/ali učinkovitosti.
English: 4.5 Interaction with other medicinal products and other forms of interaction
Slovenian: 4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Na presnovo repaglinida lahko vplivajo številna zdravila, zato mora zdravnik upoštevati možne interakcije:
English: Repaglinide Teva 0.5 mg tablets EU/1/09/530/001-005
Slovenian: Repaglinid Teva 0,5 mg tablete EU/1/09/530/001-005
English: • If you have a severe liver disease.
Slovenian: • če imate težave z jetri.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed.
Slovenian: Če je sočasna uporaba obeh zdravil nujna, je potrebno pazljivo spremljati vrednosti glukoze v krvi in bolnika natančno klinično spremljati.
English: Marketing Authorisation Holder Teva B.V.
Slovenian: Imetnik dovoljenja za promet z zdravilom: Teva B.V.
English: Warnings and precautions Talk to your doctor before taking Repaglinide Teva:
Slovenian: Pred začetkom jemanja zdravila Repaglinid Teva se posvetujte z zdravnikom:
English: In a study conducted in healthy volunteers, the concomitant administration of repaglinide (a single dose of 0.25 mg) and ciclosporin (repeated dose at 100 mg) increased repaglinide AUC and Cmax about 2.5-fold and 1.8-fold respectively.
Slovenian: V študiji pri zdravih prostovoljcih se je pri sočasni uporabi repaglinida (enkratni odmerek po 0,25 mg) in ciklosporina (večkratni odmerki po 100 mg) AUC repaglinida zvečala za približno 2,5-krat in njegova Cmax za približno 1,8-krat.
English: Co-administration of 200 mg ketoconazole increased the repaglinide (AUC and Cmax) by 1.2-fold with profiles of blood glucose concentrations altered by less than 8% when administered concomitantly (a single dose of 4 mg repaglinide).
Slovenian: AUC in Cmax repaglinida 1,2-krat ob manj kot 8% spremenjenih profilih koncentracije glukoze v krvi, če sta bila aplicirana hkrati (repaglinid v enkratnem odmerku 4 mg).
English: EU/1/09/530/011 30 tablets EU/1/09/530/012 90 tablets EU/1/09/530/013 120 tablets EU/1/09/530/014 270 tablets EU/1/09/530/015 360 tablets
Slovenian: EU/1/09/530/011 30 tablet EU/1/09/530/012 90 tablet EU/1/09/530/013 120 tablet EU/1/09/530/014 270 tablet EU/1/09/530/015 360 tablet
English: One epidemiological study suggested an increased risk of acute coronary syndrome in repaglinide treated patients as compared to sulfonylurea treated patients (see sections 4.4 and 4.8).
Slovenian: zdravljenih z repaglinidom, v primerjavi z bolniki, zdravljenimi z derivati sulfonilsečnine (glejte poglavji 4.4 in 4.8).
English: • If you take other medicines or suffer from liver or kidney problems (see other sections of
Slovenian: • uporabljate druga zdravila ali imate težave z jetri ali ledvicami (glejte ostale dele poglavja 2 Kaj morate vedeti, preden boste vzeli zdravilo Repaglinid Teva).
English: • Stomach pain
Slovenian: • bolečine v želodcu
English: Your blood sugar may get too high (hyperglycaemia).
Slovenian: Če se vam sladkor v krvi preveč zviša Sladkor v krvi se vam lahko preveč zviša (to imenujemo hiperglikemija).
English: EU/1/09/530/006 30 tablets EU/1/09/530/007 90 tablets EU/1/09/530/008 120 tablets EU/1/09/530/009 270 tablets EU/1/09/530/010 360 tablets
Slovenian: EU/1/09/530/006 30 tablet EU/1/09/530/007 90 tablet EU/1/09/530/008 120 tablet EU/1/09/530/009 270 tablet EU/1/09/530/010 360 tablet
English: Repaglinide Teva 0.5 mg tablets Each tablet contains 0.5 mg of repaglinide.
Slovenian: Repaglinid Teva 0,5 mg tablete Ena tableta vsebuje 0,5 mg repaglinida.
English: Repaglinide Teva 1 mg tablets Each tablet contains 1 mg of repaglinide.
Slovenian: Repaglinid Teva 1 mg tablete Ena tableta vsebuje 1 mg repaglinida.
English: Repaglinide Teva 2 mg tablets Each tablet contains 2 mg of repaglinide.
Slovenian: Repaglinid Teva 2 mg tablete Ena tableta vsebuje 2 mg repaglinida.
English: In an interaction study with healthy volunteers, co-administration of deferasirox (30 mg/kg/day, 4 days), a moderate inhibitor of CYP2C8 and CYP3A4, and repaglinide (single dose, 0.5 mg) resulted in an increase in repaglinide systemic exposure (AUC) to 2.3-fold (90% CI [2.03-2.63]) of control, a 1.6-fold (90% CI [1.42-1.84]) increase in Cmax, and a small, significant decrease in blood glucose values.
Slovenian: kot CYP3A4, ter repaglinida (enkratni odmerek 0,5 mg) sistemska izpostavljenost (AUC) repaglinidu povečala za 2,3-krat (90-odstotni interval zaupanja [2,03-2,63]) kontrolne vrednosti, vrednost Cmax povečala za 1,6-krat (90-odstotni interval zaupanja [1,42-1,84]), vrednost glukoze v krvi pa nekoliko pomembno zmanjšala.
English: EU/1/09/530/001 30 tablets EU/1/09/530/002 90 tablets EU/1/09/530/003 120 tablets EU/1/09/530/004 270 tablets EU/1/09/530/005 360 tablets
Slovenian: EU/1/09/530/001 30 tablet EU/1/09/530/002 90 tablet EU/1/09/530/003 120 tablet EU/1/09/530/004 270 tablet EU/1/09/530/005 360 tablet
English: Co-administration of gemfibrozil (600 mg twice daily), an inhibitor of CYP2C8, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC 8.1-fold and Cmax 2.4-fold in healthy volunteers.
Slovenian: Sočasna uporaba gemfibrozila (600 mg dvakrat dnevno) zaviralca CYP2C8, in repaglinida (enkratni odmerek 0,25 mg), je pri zdravih prostovoljcih zvečalaAUC repaglinida za 8,1-krat inCmax za 2,4-krat.
English: NAME OF THE MEDICINAL PRODUCT Repaglinide Teva 0.5 mg tablets Repaglinide Teva 1 mg tablets Repaglinide Teva 2 mg tablets
Slovenian: IME ZDRAVILA Repaglinid Teva 0,5 mg tablete Repaglinid Teva 1 mg tablete Repaglinid Teva 2 mg tablete
English: INFORMATION IN BRAILLE Repaglinide Teva 0.5 mg tablets
Slovenian: PODATKI V BRAILLOVI PISAVI Repaglinid Teva 0,5 mg tablete
English: In an interaction study in healthy volunteers, co-administration of 250 mg clarithromycin, a potent mechanism based inhibitor of CYP3A4, slightly increased the repaglinide (AUC) by 1.4-fold and Cmax by 1.7-fold and increased the mean incremental AUC of serum insulin by 1.5-fold and the maximum concentration by 1.6-fold.
Slovenian: V študiji interakcij na zdravih prostovoljcih je sočasna uporaba 250 mg klaritromicina, ki močno zavira encimski mehanizem CYP3A4, AUC repaglinida nekoliko zvečala za 1,4-krat in Cmax za 1,7-krat,
English: - If you get any side effects, talk to your doctor or pharmacist.
Slovenian: - Če opazite kateri koli neželeni učinek, se posvetujte z zdravnikom ali farmavcevtom.
English: See section 4.
Slovenian: 4.4 in 4.5.
English: ), the results showed a significant 2-fold increase of the exposure (AUC) and half-life (t½) as compared to patients with normal renal function.
Slovenian: (t1/2) v primerjavi z bolniki z normalnim delovanjem ledvic.
English: NAME OF THE MEDICINAL PRODUCT Repaglinide Teva 2 mg tablets Repaglinide
Slovenian: IME ZDRAVILA Repaglinid Teva 2 mg tablete repaglinid
English: INFORMATION IN BRAILLE Repaglinide Teva 1 mg tablets
Slovenian: PODATKI V BRAILLOVI PISAVI Repaglinid Teva 1 mg tablete
English: NAME OF THE MEDICINAL PRODUCT Repaglinide Teva 0.5 mg tablets Repaglinide
Slovenian: IME ZDRAVILA Repaglinid Teva 0,5 mg tablete repaglinid
English: INFORMATION IN BRAILLE Repaglinide Teva 2 mg tablets
Slovenian: PODATKI V BRAILLOVI PISAVI Repaglinid Teva 2 mg tablete
English: NAME OF THE MEDICINAL PRODUCT Repaglinide Teva 1 mg tablets Repaglinide
Slovenian: IME ZDRAVILA Repaglinid Teva 1 mg tablete repaglinid
English: Repaglinide should not be used in breast-feeding women.
Slovenian: Študij o uporabi repaglinida pri doječih materah ni. Doječe matere repaglinida ne smejo uporabljati.
English: Povidone K-30
Slovenian: CYP3A4.
English: Frequency not known
Slovenian: Neznana pogostnost (pogostnosti iz razpoložljivih podatkov ni mogoče oceniti)
English: You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low.
Slovenian: Če se vam sladkor v krvi preveč zniža, lahko doživite hipo (hipa je okrajšava za hipoglikemijo in pomeni simptome nizkega sladkorja v krvi).
English: Repaglinide Teva 0.5 mg tablets Repaglinide Teva 1 mg tablets Repaglinide Teva 2 mg tablets Repaglinide
Slovenian: Navodilo za uporabo Repaglinid Teva 0,5 mg tablete Repaglinid Teva 1 mg tablete Repaglinid Teva 2 mg tablete repaglinid
English: You should not take Repaglinide Teva if you are breast-feeding.
Slovenian: Ne jemljite zdravila Repaglinid Teva, če dojite.
English: If concomitant use is necessary, careful monitoring of blood glucose and close clinical monitoring should be performed (see section 4.4).
Slovenian: Če je sočasna uporaba nujna, je treba bolnika skrbno klinično spremljati in nadzirati vrednosti glukoze v krvi (glejte poglavje 4.4).
English: However, the benefit risk profile remains to be established when comparing to other combination therapies.
Slovenian: Tveganje za pojav hipe se lahko poveča, če jemljete druga zdravila.
English: Repaglinide Teva 1 mg tablet is a yellow to light yellow, capsule shaped tablet, debossed with "93" on one side and “211” on the other side of the tablet.
Slovenian: Zdravilo Repaglinid Teva 1 mg tablete je rumena do svetlo rumena tableta v obliki kapsule, z vgraviranim napisom “93” na eni strani in “211” na drugi strani tablete.
English: Co-administration of trimethoprim (160 mg twice daily), a moderate CYP2C8 inhibitor, and repaglinide (a single dose of 0.25 mg) increased the repaglinide AUC, Cmax and t½ (1.6-fold, 1.4-fold and 1.2-fold respectively) with no statistically significant effects on the blood glucose levels.
Slovenian: Sočasna aplikacija trimetoprima (160 mg dvakrat dnevno), srednje močnega zaviralca CYP2C8, in repaglinida (v enkratnem odmerku 0,25 mg) je povečala AUC, Cmax int1/2 repaglinida (1,6-krat,
English: • Deferasirox (used to reduce chronic iron overload).
Slovenian: • deferasiroks (uporabljamo ga za zdravljenje kronične preobremenitve z železom), • klopidogrel (zdravilo, ki preprečuje nastajanje krvnih strdkov),
English: • If you have an infection or a fever.
Slovenian: • ste vzeli premalo zdravila Repaglinid Teva, • imate okužbo ali zvišano telesno temperaturo,
English: How to store Repaglinide Teva
Slovenian: Shranjevanja zdravila Repaglinid Teva
English: • If you take gemfibrozil (a medicine used to lower increased fat levels in the blood).
Slovenian: • če imate hudo bolezen jeter, • če jemljete gemfibrozil (zdravilo za zdravljenje zvišanih maščob v krvi).
English: Repaglinide Teva 2 mg tablet is a mottled peach, capsule shaped tablet, debossed with "93" on one side and “212” on the other side of the tablet.
Slovenian: Zdravilo Repaglinid Teva 2 mg tablete je tableta lisasto breskove barve v obliki kapsule, z vgraviranim napisom “93” na eni strani in “212” na drugi strani tablete.
English: Intraindividual variability is low to moderate (35%) and as repaglinide should be titrated against the clinical response, efficacy is not affected by interindividual variability.
Slovenian: Variabilnost pri posameznem bolniku je majhna do zmerna (35 %),
English: Metabolism and nutrition disorders
Slovenian: Kombinacija z metforminom
English: A number of medicinal products are known to influence repaglinide metabolism.
Slovenian: - Zdravilna učinkovina je repaglinid.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 0.5 mg of repaglinide.
Slovenian: Ena tableta vsebuje 0,5 mg repaglinida.
English: Repaglinide Teva 2 mg tablets Microcrystalline cellulose (E460) Meglumine
Slovenian: Repaglinid Teva 2 mg tablete mikrokristalna celuloza (E460) meglumin poloksamer 188 povidon K-30 brezvodni kalcijev hidrogenfosfat brezvodni koloidni silicijev dioksid polakrilin kalij koruzni škrob magnezijev stearat rdeči železov oksid (E172)
English: Repaglinide Teva 0.5 mg tablet is a light blue to blue, capsule shaped tablet, debossed with "93" on one side and “210” on the other side of the tablet.
Slovenian: Izgled zdravila Repaglinid Teva in vsebina pakiranja Zdravilo Repaglinid Teva 0,5 mg tablete je svetlo modra do modra tableta v obliki kapsule, z vgraviranim napisom “93” na eni strani in “210” na drugi strani tablete.
English: Be aware that the desired effect is not achieved if you stop taking Repaglinide Teva.
Slovenian: Vedite, da s prenehanjem jemanja zdravila Repaglinid Teva izgubite željeni učinek na znižanje sladkorja v krvi.
English: At such times diabetic control may be lost.
Slovenian: V takšnih okoliščinah lahko vaša sladkorna bolezen postane neurejena;
English: Repaglinide Teva 1 mg tablets Microcrystalline cellulose (E460) Meglumine
Slovenian: Repaglinid Teva 1 mg tablete mikrokristalna celuloza (E460) meglumin poloksamer 188 povidon K-30 brezvodni kalcijev hidrogenfosfat brezvodni koloidni silicijev dioksid polakrilin kalij koruzni škrob magnezijev stearat rumeni železov oksid (E172)
English: • ACE-inhibitors (used to treat heart conditions).
Slovenian: • zaviralce angiotenzinske konvertaze (zaviralce ACE; uporabljajo se za zdravljenje bolezni srca),
English: Repaglinide Teva 2 mg tablets Mottled peach, capsule shaped tablet, debossed with "93" on one side and “212” on the other side.
Slovenian: Tableta lisasto breskove barve v obliki kapsule, z vgraviranim napisom “93” na eni strani in “212” na drugi strani tablete.
English: Repaglinide Teva 1 mg tablets Yellow to light yellow, capsule shaped tablet, debossed with "93" on one side and “211” on the other.
Slovenian: Rumena do svetlo rumena tableta v obliki kapsule, z vgraviranim napisom “93” na eni strani in “211” na drugi strani tablete.
English: Bear in mind that you could endanger yourself or others.
Slovenian: Vedite, da lahko to ogrozi vas in druge (ljudi okoli vas).
English: Please see If you get a hypo on what a hypo is and how to treat it.
Slovenian: Za razlago in navodila za odpravo hipe prosim glejte odstavek V primeru pojava hipe.
English: Repaglinide Teva 0.5 mg tablets Microcrystalline cellulose (E460) Meglumine
Slovenian: FARMACEVTSKI PODATKI 6.1 Seznam pomožnih snovi Repaglinid Teva 0,5 mg tablete mikrokristalna celuloza (E460) meglumin poloksamer 188 povidon K-30 brezvodni kalcijev hidrogenfosfat brezvodni koloidni silicijev dioksid polakrilin kalij koruzni škrob magnezijev stearat indigotin (E132)
English: Tell your doctor what happened.
Slovenian: Povejte zdravniku, kaj se je zgodilo.
English: *See next section below
Slovenian: *Glejte naslednje poglavje spodaj.
English: Date of first authorisation: 31 August 2010 Date of latest renewal: 17 July 2015
Slovenian: Datum prve odobritve: 31. avgust 2010 Datum zadnjegapodaljšanja: 17. julij 2015
English: Repeat step 5 three times.
Slovenian: Korak 5 ponovite trikrat.
English: The patient should be instructed how to do this correctly.
Slovenian: Bolnik mora biti poučen o tem, kako naj to pravilno stori.
English: It is very important to follow your doctor's instructions.
Slovenian: Zelo pomembno je, da se ravnate po zdravnikovih navodilih.
English: One hundred of these patients continued treatment for up to 26 months in an extension phase.
Slovenian: Sto od teh bolnikov je nadaljevalo zdravljenje v fazi podaljšanja do 26 mesecev.
English: • not knowing where you are (disorientated)
Slovenian: • ne veste, kje ste (dezorientiranost),
English: This should clear any blockage.
Slovenian: To bi moralo odstraniti blokado.
English: • Information on the correct indication
Slovenian: • informacije o pravilni indikaciji;
English: Abuse potential and tolerance
Slovenian: Možnost zlorabe in toleranca
English: How much to use
Slovenian: Koliko uporabiti
English: The relevance of these findings to humans is unknown.
Slovenian: Pomen teh izsledkov za ljudi ni znan.
English: Clinical signs and symptoms may be manifest from these hormonal changes.
Slovenian: Lahko so vidni klinični znaki in simptomi zaradi teh hormonskih sprememb.
English: This is called ‘priming'.
Slovenian: To se imenuje aktiviranje.
English: • Do not change the dose yourself.
Slovenian: • Odmerka ne spreminjajte sami.
English: Sit down with your head upright.
Slovenian: Sedite z glavo pokonci.
English: • You will NOT hear a click when you press down .
Slovenian: • Pri pritiskanju NE boste slišali klika.
English: Bottles contain:
Slovenian: Steklenice vsebujejo:
English: This will tilt the bottle slightly (Figure 5).
Slovenian: S tem boste steklenico rahlo nagnili (slika 5).
English: Your doctor will tell you how many sprays (1 or 2) you should use to treat your breakthrough pain episode.
Slovenian: Zdravnik vam bo povedal, koliko vpihov (1 ali 2) morate uporabiti za zdravljenje svoje epizode prebijajoče bolečine.
English: Elderly (older than 65 years)
Slovenian: Posebne populacije Starejši bolniki (starejši od 65 let)
English: Patients should be carefully monitored until an effective dose is reached.
Slovenian: Bolnike moramo skrbno spremljati, dokler ne dosežemo učinkovitega odmerka.
English: Never try to fix the nasal spray yourself or take it apart.
Slovenian: Nikoli ne poskušajte sami popraviti pršila za nos ali ga razstaviti.
English: • you suffer a severe blow to the head
Slovenian: • ste doživeli močan udarec v glavo;
English: Its primary therapeutic actions are analgesia and sedation.
Slovenian: Njegova primarna terapevtska učinka sta analgezija in sedacija.
English: The main pharmacokinetic parameters are shown in the following table.
Slovenian: Glavni farmakokinetični parametri so prikazani v naslednji preglednici.